Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenues:
Total revenues	$ 40,626	$ 11,992
Expenses:
Cost of goods sold	5,530	2,284
Research and development	5,605	3,536
Selling	13,310	12,728
General and administrative	10,542	7,969
Loss (gain) on foreign currency transaction	954	(1,983)
Total expenses	46,624	33,248
Loss from operations	(5,998)	(21,256)
Other (expense) income:
Interest income, net	1,302	377
Interest expense on financing liability	(2,424)	(2,371)
Interest expense on notes	(2,786)	(2,748)
Other income	111
Total other expense	(3,797)	(4,742)
Loss before income tax expense	(9,795)	(25,998)
Benefit from income taxes	0	0
Net loss	$ (9,795)	$ (25,998)
Net loss per share - basic	$ (0.04)	$ (0.10)
Net loss per share - diluted	$ (0.04)	$ (0.10)
Shares used to compute net loss per share - basic	263,969	251,887
Shares used to compute net loss per share - diluted	263,969	251,887
Commercial product sales
Revenues:
Total revenues	$ 17,562	$ 9,826
Collaborations and services
Revenues:
Total revenues	11,386	2,166
Expenses:
Cost of revenue	10,683	$ 8,714
Royalties collaborations
Revenues:
Total revenues	$ 11,678